PDK1 and breast carcinoma: The metabolic switch mediated by PDK1 has been shown to support malignant phenotypes in vitro such as head-and-neck squamous cell carcinoma (HNSC) resistance to hypoxia-induced cell death13, breast cancer cell anoikis resistance14, oncogene-induced senescence in melanomas15, and breast cancer stem cell reprogramming16.